Rifaximin treatment in hepatic encephalopathy.
Xue
Tao
T
Qiu
Jian-hua
JH
Qiao
Li
L
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000150:complications / Q000517:prevention & control*; D048550:Hepatic Insufficiency / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D017114:Liver Failure, Acute / Q000150:complications; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin